Lifebit Raises $60M To Make Vital Biomedical Data Securely Accessible For Life Changing Research Worldwide
Lifebit Raises $60M To Make Vital Biomedical Data Securely Accessible For Life Changing Research Worldwide
09/29/21, 12:07 AM
Location
londonMoney raised
$60 million
Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data for governments, healthcare providers and research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm Tiger Global Management. Existing investors Eurazeo, Pentech Ventures, and Beacon Capital also participated.
Company Info
Location
london, ontario, canada
Additional Info
Lifebit builds enterprise data platforms for use by organisations with complex and sensitive biomedical datasets. Lifebit's patented federated technology securely unlocks access to biomedical data. From providing Trusted Research Environments for national precision medicine programmes to enabling pharmaceutical companies to discover new drug targets faster, Lifebit empowers customers to transform how they leverage sensitive biomedical data.